Catalyst Wire Dossier Catalyst Wire Dossier

RVT-501 topical ointment

RVT-501 · Dermavant Sciences GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RVT-501 topical ointment, covering 2018-05-11 to 2018-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis [Phase 2]

See pricing